Emergent BioSolutions
EBS
#8341
Rank
NZ$0.55 B
Marketcap
NZ$10.85
Share price
3.59%
Change (1 day)
-44.43%
Change (1 year)

Operating Margin for Emergent BioSolutions (EBS)

Operating Margin as of November 2026 (TTM): 11.74%

According to Emergent BioSolutions 's latest financial reports and stock price the company's current Operating Margin is 11.74%. At the end of 2021 the company had an Operating Margin of 17.54%.

Operating Margin history for Emergent BioSolutions from 2004 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202117.54%-33.01%
202026.18%274.09%
20197.00%-32.82%
201810.42%-50.75%
201721.15%4.2%
201620.30%18.22%
201517.17%45.67%
201411.79%-14.99%
201313.87%21.9%
201211.38%-2.65%
201111.68%-54.42%
201025.64%45%
200917.68%-3.57%
200818.33%-6.81%
200719.67%-20.96%
200624.89%54.1%
200516.15%-18.76%
200419.88%-80.12%
2003100.00%111.56%
200247.27%-3965.85%
2001-1.22%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01% 2.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40% 175.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
16.02% 36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-5,981.30%-51,048.04%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
32.12% 173.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-16,748.00%-142,757.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
7.08%-39.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.